Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 4
1976 5
1977 5
1978 4
1979 9
1980 4
1981 5
1982 1
1983 4
1984 3
1985 4
1986 6
1987 8
1988 8
1989 9
1990 4
1991 6
1992 3
1993 5
1994 3
1995 3
1996 1
1997 5
1998 3
1999 10
2000 5
2001 11
2002 10
2003 20
2004 19
2005 18
2006 8
2007 20
2008 22
2009 27
2010 19
2011 24
2012 20
2013 26
2014 28
2015 25
2016 27
2017 28
2018 27
2019 35
2020 48
2021 56
2022 66
2023 56
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

705 results

Results by year

Filters applied: . Clear all
Page 1
Juvenile Polyposis of the Stomach.
Tanaka K, Umeda Y, Nakagawa H. Tanaka K, et al. Among authors: umeda y. Am J Gastroenterol. 2023 Jan 1;118(1):16. doi: 10.14309/ajg.0000000000001990. Epub 2022 Sep 1. Am J Gastroenterol. 2023. PMID: 36066479 No abstract available.
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma.
Yoshimoto M, Kagawa S, Kajioka H, Taniguchi A, Kuroda S, Kikuchi S, Kakiuchi Y, Yagi T, Nogi S, Teraishi F, Shigeyasu K, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Yoshimoto M, et al. Among authors: umeda y. Cancer Lett. 2023 Jul 28;567:216260. doi: 10.1016/j.canlet.2023.216260. Epub 2023 Jun 7. Cancer Lett. 2023. PMID: 37295551
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Bai X, Shaheen A, Grieco C, d'Arienzo PD, Mina F, Czapla JA, Lawless AR, Bongiovanni E, Santaniello U, Zappi H, Dulak D, Williamson A, Lee R, Gupta A, Li C, Si L, Ubaldi M, Yamazaki N, Ogata D, Johnson R, Park BC, Jung S, Madonna G, Hochherz J, Umeda Y, Nakamura Y, Gebhardt C, Festino L, Capone M, Ascierto PA, Johnson DB, Lo SN, Long GV, Menzies AM, Namikawa K, Mandala M, Guo J, Lorigan P, Najjar YG, Haydon A, Quaglino P, Boland GM, Sullivan RJ, Furness AJS, Plummer R, Flaherty KT. Bai X, et al. Among authors: umeda y. EClinicalMedicine. 2023 Oct 31;65:102290. doi: 10.1016/j.eclinm.2023.102290. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37965433 Free PMC article.
Feasibility of local therapy for recurrent pancreatic cancer.
Sato H, Yoshida R, Yasui K, Umeda Y, Yoshida K, Fuji T, Kumano K, Takagi K, Yagi T, Fujiwara T. Sato H, et al. Among authors: umeda y. Pancreatology. 2022 Sep;22(6):774-781. doi: 10.1016/j.pan.2022.05.004. Epub 2022 May 24. Pancreatology. 2022. PMID: 35641368 Review.
Ultrafast olivine-ringwoodite transformation during shock compression.
Okuchi T, Seto Y, Tomioka N, Matsuoka T, Albertazzi B, Hartley NJ, Inubushi Y, Katagiri K, Kodama R, Pikuz TA, Purevjav N, Miyanishi K, Sato T, Sekine T, Sueda K, Tanaka KA, Tange Y, Togashi T, Umeda Y, Yabuuchi T, Yabashi M, Ozaki N. Okuchi T, et al. Among authors: umeda y. Nat Commun. 2021 Jul 14;12(1):4305. doi: 10.1038/s41467-021-24633-4. Nat Commun. 2021. PMID: 34262045 Free PMC article.
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration.
Morinaga T, Inozume T, Kawazu M, Ueda Y, Sax N, Yamashita K, Kawashima S, Nagasaki J, Ueno T, Lin J, Ohara Y, Kuwata T, Yukami H, Kawazoe A, Shitara K, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Kawahara Y, Nakamura Y, Kiniwa Y, Morita A, Ichihara E, Kiura K, Enokida T, Tahara M, Hasegawa Y, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Morinaga T, et al. Among authors: umeda y. Cancer Res Commun. 2022 Jul 28;2(7):739-753. doi: 10.1158/2767-9764.CRC-22-0050. eCollection 2022 Jul. Cancer Res Commun. 2022. PMID: 36923281 Free PMC article.
RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
Takahashi K, Shigeyasu K, Kondo Y, Gotoh K, Yano S, Umeda Y, Inokuchi T, Xu C, Yoshida K, Umeda H, Takahashi T, Takeda S, Yoshida R, Teraishi F, Kishimoto H, Mori Y, Noma K, Okugawa Y, Hiraoka S, Michiue H, Tazawa H, Matsushita O, Goel A, Fujiwara T. Takahashi K, et al. Among authors: umeda y. J Crohns Colitis. 2023 May 3;17(5):754-766. doi: 10.1093/ecco-jcc/jjac186. J Crohns Colitis. 2023. PMID: 36528792 Free article.
705 results